Clinical Trial

Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are \<13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF). The main question\[s\] it aims to answer \[is/are\]: Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care? Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?
Protocol Amendment History 7 changes
notable Primary completion pushed: 2026-06-30 -> 2026-09-30 2026-07-08
minor Completion pushed: 2026-09-30 -> 2026-10-30 2026-07-08
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-07-01
critical Primary endpoint(s) modified 2026-07-01
notable Enrollment reduced: 72 -> 36 participants 2026-07-01
notable Primary completion moved earlier: 2026-09-30 -> 2026-06-30 2026-07-01
minor Completion moved earlier: 2026-12-15 -> 2026-09-30 2026-07-01
Trial Details
NCT Number NCT07491510
Lead Sponsor University of Kansas Medical Center
Collaborators: National Institute of General Medical Sciences (NIGMS)
Conditions Monitoring Blood Pressure, Aspirin Prophylaxis
Enrollment 36 participants
Start Date 2026-03-02
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14